On Wednesday 28th August 2024, Phibro Animal Health (NASDAQ: PAHC) will be releasing its fourth quarter financial results. This much awaited announcement will be made after market close.
Financial analysts on Wall Street are anticipating that the organization will announce an estimated $0.33 profit per share for the quarter. Furthermore, the firm is projected to disclose a total revenue of $263.24 million for this period.
The company's earnings report for the corresponding quarter of the previous year showcased a per-share income of $0.38. This figure was a result of the company's total revenue, which reached an impressive $255 million million during that specific period.
Wall Street analysts have revealed their projections for the company's yearly performance, with a total revenue of $1 billion. Furthermore, they expect the business to achieve profit of $1.12 per share during the fiscal year.
| Period | EPS Actual |
EPS Growth* |
Revenue Actual |
Revenue Growth* |
|---|---|---|---|---|
| Q3 2024 | $0.31 | +6.9% | 263.20 M | +7.1% |
| Q2 2024 | $0.33 | -2.9% | 249.90 M | +2.2% |
| Q1 2024 | $0.14 | -33.3% | 231.30 M | -0.5% |
| Q4 2023 | $0.38 | +5.6% | 255.00 M | -0.1% |
*Growth on year-over-year basis
Additionally, The company will host a conference call with investors and analysts on 29th August 2024 at 09:00 AM eastern time to review the Q4 2024 financial results.
The previous trading day saw Phibro Animal Health (PAHC) shares trading between $18.79 and $21.09, besides a volume of 430.70 thousand shares. The stock closed Friday's regular trading session at $20.94, showing 10.15 percent increase.
